Upgrade to SI Premium - Free Trial

Citi Resumes GlaxoSmithKline (GSK:LN) (GSK) at Neutral

July 24, 2026 4:55 AM
Citi analyst Graham Parry resumes ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Intl Ratings New Coverage